| Clinical data | |
|---|---|
| Trade names | Celospor, Celtol, Cristacef |
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Intravenous, intramuscular, intramammary |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Protein binding | 23 to 38% |
| Elimination half-life | 1.2 hours |
| Excretion | Renal (72%) |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank |
|
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.030.449 |
| Chemical and physical data | |
| Formula | C13H13N3O6S |
| Molar mass | 339.32 g·mol−1 |
| 3D model (JSmol) | |
| |
| (verify) | |
Cefacetrile (INN, also spelled cephacetrile) is a broad-spectrum first generation cephalosporin antibiotic effective in gram-positive and gram-negative bacterial infections. It is a bacteriostatic antibiotic.12 Cefacetrile is marketed under the trade names Celospor, Celtol, and Cristacef,3 and as Vetimast for the treatment of mammary infections in lactating cows.2
Synthesis

It was made by reacting 7-ACA (7-aminocephalosporanic acid) with cyanoacetyl chloride in the presence of tributylamine.
References
References
- "Cefacetrile Summary Report" (PDF). European Medicines Agency, Committee for Veterinary Medicinal Products. 1998. Archived from the original (PDF) on 2020-05-26. Retrieved 2012-01-25.
- Haberfeld H, ed. (2007). Austria-Codex (in German) (2007/2008 ed.). Vienna: Österreichischer Apothekerverlag. ISBN 978-3-85200-183-8.
- Horiuchi N, Oyakawa Y, Oka R, Fujiwara T (October 1980). "[Clinical evaluation of cephacetrile (Celtol) for respiratory infections (author's transl)]". The Japanese Journal of Antibiotics. 33 (10): 1145–55. PMID 7206219.